RISE to the Challenge: Statistical Considerations for Rare Disease Clinical Investigations - 09/29/2026

This public workshop, co-convened by Duke Margolis and the FDA Rare Disease Innovation Hub, will explore statistical considerations in the design, conduct, and analysis of clinical investigations for rare disease medical products.